| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
| 02/02/2011 | CN101965194A Vaccine compositions |
| 02/02/2011 | CN101965193A Improved methods and compositions for wound healing |
| 02/02/2011 | CN101965192A Antitumoral treatments |
| 02/02/2011 | CN101965191A Improved anticancer treatments |
| 02/02/2011 | CN101965190A Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways |
| 02/02/2011 | CN101962651A L-methionine gamma-lyase gene from deep sea metagenome and expression product thereof |
| 02/02/2011 | CN101962413A Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
| 02/02/2011 | CN101962404A Protein used for treating hemangioma |
| 02/02/2011 | CN101962402A Astragalus membranaceus glycoprotein as well as preparation method and usage thereof |
| 02/02/2011 | CN101961493A Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 02/02/2011 | CN101961486A 一种滴眼液及其制备方法 One kind of eye drops and its preparation method |
| 02/02/2011 | CN101961485A Selenium-enriched collagen and inulin composition with functions of enhancing immunity and reducing blood sugar |
| 02/02/2011 | CN101961484A Prostate secretory protein 94/57 (Psp94/57), analogous polypeptides thereof for preparing medicaments for eliminating drug (therapy) resistance of tumor, and application thereof |
| 02/02/2011 | CN101961483A Application of intramembrane segment of amyloid protein to preparing drug for treating Alzheimer's disease |
| 02/02/2011 | CN101961482A Immunity enhancer for aquatic animals |
| 02/02/2011 | CN101961314A Novel nanoemulsion drug loading system for protein drugs and preparation method thereof |
| 02/02/2011 | CN101362803B Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/02/2011 | CN101260147B Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 02/02/2011 | CN101228179B A process for the preparation of perindopril erbumine |
| 02/02/2011 | CN101015682B Medicine composition with compact bone substance density improving function, preparing process and quality controlling means thereof |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| 02/01/2011 | US7879982 19.5 polypeptide antibodies useful for diagnosing or treating psoriasis |
| 02/01/2011 | US7879980 Monoclonal antibodies to human CTLA-8 (IL-17A) |
| 02/01/2011 | US7879976 Method for stabilizing a protein |
| 02/01/2011 | US7879975 Sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution |
| 02/01/2011 | US7879974 Sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879869 Drugs for ameliorating postcibal hyperglycemia |
| 02/01/2011 | US7879831 Enhanced drug delivery in transdermal systems |
| 02/01/2011 | US7879821 Method for modulating inflammatory responses by altering plasma lipid levels |
| 02/01/2011 | US7879819 Nanoparticles for protein drug delivery |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879805 High temperature stable peptide formulation |
| 02/01/2011 | US7879804 Nutraceutical, medicament; peptides isoleucine-proline-proline and valine-proline-proline from casein; dietary supplement or a personal care application; topical lotion, gel; emulsion, food, beverage, feed or pet food ingredient |
| 02/01/2011 | US7879803 Methods of treatment involving the protease for activating clotting factor VII |
| 02/01/2011 | US7879802 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/01/2011 | US7879801 For therapy of cancer and viral infections |
| 02/01/2011 | US7879800 Purification of API from blood plasma or from plasma fractions to obtain pharmaceutical grade API on a commercial scale and is highly stable |
| 02/01/2011 | US7879799 Preparing immunoglobulin specific for deglycosylated membrane proteins; for use in monitoring dynamic organization of the plasma membranes |
| 02/01/2011 | US7879798 Composition for indolent wound healing and methods of use therefor |
| 02/01/2011 | US7879797 HCV NS3 protease inhibitors |
| 02/01/2011 | US7879796 Amino acid composition for improving glucose tolerance |
| 02/01/2011 | US7879795 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide |
| 02/01/2011 | US7879794 administering amylin or amylin agonist such as promlinitide; to prevent, treat or controlling conditions or disorders associated with obesity, diet, and nutrition |
| 02/01/2011 | US7879793 Treatment of medical condition with A2 domain of von willebrand factor |
| 02/01/2011 | US7879792 Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 02/01/2011 | US7879791 Regulation of T cell-mediated immunity by tryptophan |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879605 Methods and compositions for tissue regeneration |
| 02/01/2011 | US7879588 Protein-proteophore complexes |
| 02/01/2011 | US7879578 Self-assembled proteins and related methods and protein structures |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879558 Diagnostic markers for ischemia |
| 02/01/2011 | US7879341 from Clostridium botulinum, neurotoxin being free of complexing proteins naturally present; improved stability via hyaluronic acid, polyvinylpyrrolidone and polyethyleneglycol; cryoprotectants; cosmetic conditions, blepharospasm, hemifacial spasms, spasmodic torticollis, spasticities, migraine, back pain |
| 02/01/2011 | US7879340 blocking, reducing allergic rhinitis via antibodies contacting antigen, by administration of neurotoxin derived from Clostridium; absorbent pledgets, biodegradable carriers; lyophilization; liposomes |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879320 Sustained release interferon dosage form for use in treatment of multiple sclerosis |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 02/01/2011 | US7879315 such as inositol phosphoric acid esters (phytic acid), polyphenols (Perilla frutescen var. crispa polyphenols), perilla extract comprising rosmarinic acid, phosphoric acids, edetic acid salts, tartaric acid, malic acid, citric acid, and glycolic acid |
| 02/01/2011 | US7879111 System and method for RFID transfer of MAC, keys |
| 02/01/2011 | US7878786 Apparatus for producing tissue scaffold having aligned fibrils |
| 02/01/2011 | CA2641952C Treatment of early stage idiopathic pulmonary fibrosis |
| 02/01/2011 | CA2470971C Use of pharmaceutical composition containing epidermal growth factor (egf) for preventing diabetic limb amputation |
| 02/01/2011 | CA2445260C Buffer solution for electroporation and a method comprising the use of the same |
| 02/01/2011 | CA2442917C Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/01/2011 | CA2425172C Methods of decreasing or preventing pain using spicamycin derivatives |
| 02/01/2011 | CA2408685C Liquid pharmaceutical composition containing an erythropoietin derivate |
| 02/01/2011 | CA2405508C Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 02/01/2011 | CA2404368C Pharmaceutical compositions |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2354508C Streptococcal c5a peptidase vaccine |
| 02/01/2011 | CA2345882C Methods and compositions for the prevention and treatment of anemia |
| 02/01/2011 | CA2342133C Ophthalmic formulations |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 02/01/2011 | CA2288943C Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/01/2011 | CA2274902C Submucosa extracts |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2219978C Method for inhibiting neoplastic disease in mammals |
| 02/01/2011 | CA2189143C A method of modifying angiotensin receptor activity for treatment of premenstrual syndrome and mediation of pain |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 02/01/2011 | CA1341609C Novel human tissue-type plasminogen activator variant |
| 01/27/2011 | WO2011011789A1 Methods and compositions for treating neuronal damage or degeneration |
| 01/27/2011 | WO2011011753A1 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | WO2011011733A2 Factor replacement therapy |
| 01/27/2011 | WO2011011713A1 Compositions and methods of use for post-radiation protection |
| 01/27/2011 | WO2011011710A1 Methods of treating viral infections |
| 01/27/2011 | WO2011011706A2 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| 01/27/2011 | WO2011011675A1 Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
| 01/27/2011 | WO2011011513A1 Inhibition of pathological bone formation |
| 01/27/2011 | WO2011011384A2 Synthesis of dendrimer conjugates |
| 01/27/2011 | WO2011011315A1 POLYPEPTIDES SELECTIVE FOR AV β3 INTEGRIN CONJUGATED WITH A VARIANT OF HUMAN SERUM ALBUMIN (HSA) AND PHARMACEUTICAL USES THEREOF |